• Acrux talks 18th annual Bioshares Biotech Summit

  • Jul 17 2024
  • Duración: 7 m
  • Podcast

Acrux talks 18th annual Bioshares Biotech Summit Por arte de portada

Acrux talks 18th annual Bioshares Biotech Summit

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Acrux Ltd (ASX:ACR) CEO and managing director Michael Kotsanis is in the Proactive studio following the 18th annual Bioshares Biotech Summit in Perth. Acrux is a specialty pharma company with a successful track record of developing and commercialising a pipeline of topically applied pharmaceutical products. Drawing on 25 years of experience, Acrux has marketed through licensees a number of products worldwide with emphasis on the United States. Acrux is formulating and developing a range of topical generic products to bring affordable products to market. Acrux encourages collaboration and is positioned to discuss commercial partnering and product development opportunities. _#ProactiveInvestors #Acrux #ASX #ACR #Biotech #Bioshares #Summit #BiosharesBiotechSummit #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Más Menos
activate_primeday_promo_in_buybox_DT
Empresas y Profesiones Economía Finanzas Personales Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre Acrux talks 18th annual Bioshares Biotech Summit

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles